Richard Cunningham

1.2k total citations · 1 hit paper
9 papers, 269 citations indexed

About

Richard Cunningham is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Richard Cunningham has authored 9 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Oncology. Recurrent topics in Richard Cunningham's work include Hippo pathway signaling and YAP/TAZ (3 papers), Antimicrobial Peptides and Activities (2 papers) and Cellular Mechanics and Interactions (2 papers). Richard Cunningham is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (3 papers), Antimicrobial Peptides and Activities (2 papers) and Cellular Mechanics and Interactions (2 papers). Richard Cunningham collaborates with scholars based in United Kingdom, United States and Egypt. Richard Cunningham's co-authors include Carsten Gram Hansen, Marie E. Migaud, John G. Hardy, Rania M. Hathout, Philip Redpath, Christopher T. Elliott, Sara McNamee, Ahlam Ali, Tracy Robson and Cian M. McCrudden and has published in prestigious journals such as Cell Reports, RSC Advances and Clinical Science.

In The Last Decade

Richard Cunningham

7 papers receiving 265 citations

Hit Papers

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeu... 2022 2026 2023 2024 2022 50 100 150

Peers

Richard Cunningham
Richard Cunningham
Citations per year, relative to Richard Cunningham Richard Cunningham (= 1×) peers X. Guillory

Countries citing papers authored by Richard Cunningham

Since Specialization
Citations

This map shows the geographic impact of Richard Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Cunningham more than expected).

Fields of papers citing papers by Richard Cunningham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Cunningham. The network helps show where Richard Cunningham may publish in the future.

Co-authorship network of co-authors of Richard Cunningham

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Cunningham. A scholar is included among the top collaborators of Richard Cunningham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Cunningham. Richard Cunningham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Wang, Zhuorui, Jeanette A. Johansson, Richard Cunningham, et al.. (2025). Oncogenic Ras activation in permissive somatic cells triggers rapid-onset phenotypic plasticity and elicits a tumor-promoting neutrophil response. Cell Reports. 44(11). 116478–116478.
2.
Cunningham, Richard, Adriano G. Rossi, Justyna Cholewa-Waclaw, et al.. (2025). Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses NF2-mutant mesothelioma. Life Science Alliance. 8(10). e202503241–e202503241.
3.
Cunningham, Richard, et al.. (2023). YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations. Clinical and Translational Medicine. 13(2). e1190–e1190. 4 indexed citations
4.
Cunningham, Richard & Carsten Gram Hansen. (2022). The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. Clinical Science. 136(3). 197–222. 168 indexed citations breakdown →
5.
Cunningham, Richard, et al.. (2019). Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT. Journal of Functional Biomaterials. 10(2). 26–26. 41 indexed citations
6.
Cunningham, Richard, et al.. (2016). Solubility study of tobramycin in room temperature ionic liquids: an experimental and computational based study. RSC Advances. 6(109). 107214–107218. 2 indexed citations
7.
Pentlavalli, Sreekanth, Richard Cunningham, Cian M. McCrudden, et al.. (2016). Potentiating the Anticancer Properties of Bisphosphonates by Nanocomplexation with the Cationic Amphipathic Peptide, RALA. Molecular Pharmaceutics. 13(4). 1217–1228. 32 indexed citations
8.
Cunningham, Richard, et al.. (2015). Atom efficient synthesis of pyrimidine and purine nucleosides by ball milling. RSC Advances. 5(72). 58116–58119. 13 indexed citations
9.
McNamee, Sara, Richard Cunningham, & Christopher T. Elliott. (2013). Simultaneous immunochemical detection of four banned antibiotic growth promoters in raw and cooked poultry tissue. Food Additives & Contaminants Part A. 30(7). 1270–1278. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026